CIK 0001016178
CARV CARVER BANCORP INC
Insider trading from SEC Form 4. Last filing Dec 6, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
5
with a Form 4 at this company
Signals
Open-market buys and sells at CARVER BANCORP INC, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 54Moderate | buy 5 | Felix Donald President and CEO | $45k | 26,946 | - | - | |
| 40Moderate | buy 5 | JACKSON PAZEL G JR director | $15k | 8,982 | +142% | - | |
| 40Moderate | buy 5 | Grannum Colvin director | $20k | 11,976 | +688% | - | |
| 50Moderate | buy 5 | MacKay Craig C director | $100k | 59,880 | +1198% | - | |
| 40Moderate | buy 5 | Knuckles Kenneth director | $15k | 8,982 | +898% | - |
Transactions
The last 5 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | Felix Donald President and CEO | POpen-market purchase Common Stock | +26,946 | $1.67 | $45k | 26,946 | Dec 6, 2024 |
| Nov 25, 2024 | JACKSON PAZEL G JR director | POpen-market purchase Common Stock | +8,982 | $1.67 | $15k | 15,308 | Nov 27, 2024 |
| Nov 25, 2024 | Grannum Colvin director | POpen-market purchase Common Stock | +11,976 | $1.67 | $20k | 13,716 | Nov 27, 2024 |
| Nov 25, 2024 | MacKay Craig C director | POpen-market purchase Common Stock | +59,880 | $1.67 | $100k | 64,880 | Nov 27, 2024 |
| Nov 25, 2024 | Knuckles Kenneth director | POpen-market purchase Common Stock | +8,982 | $1.67 | $15k | 9,982 | Nov 27, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Felix DonaldPresident and CEO
- Grannum Colvindirector
- JACKSON PAZEL G JRdirector
- Knuckles Kennethdirector
- MacKay Craig Cdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.